Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Award
Common Stock
2022-01-04+40,000→ 73,138 total - Award
Stock Option (Right to Buy)
2022-01-04+80,000→ 80,000 totalExercise: $15.94Exp: 2032-01-04→ Common Stock (80,000 underlying)
Footnotes (4)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 60,000 RSUs.
- [F3]Includes 1,527 shares acquired on November 15, 2021, pursuant to Issuer's employee stock purchase plan.
- [F4]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.